Clinical Trial Update: RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA [Phase 2, Phase 3]

View source ↗

Summary

Clinical Trial Update indicating that the Phase 2/Phase 3 study of IHL-42X for obstructive sleep apnea is active but not currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• IHL-42X

Snippet

Sponsor: Incannex Healthcare Ltd | Conditions: Obstructive Sleep Apnea | Phase 2, Phase 3 | Status: ACTIVE_NOT_RECRUITING